Login / Signup

Results of the First U.S. FDA-Approved Hip Resurfacing Device at 10-Year Follow-up.

Edwin P SuHenry HoVinay BhalLawrence R HousmanJohn L MasonisJohn W NobleRobert H HopperC Anderson Engh
Published in: The Journal of bone and joint surgery. American volume (2021)
Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
Keyphrases
  • drug administration
  • total hip arthroplasty